The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective

Shamshul Ansari; John P Hays; Global AMR Insights Ambassador Network; Andrew Kemp; Raymond Okechukwu; Jayaseelan Murugaiyan; Mutshiene Deogratias Ekwanzala; Maria Josefina Ruiz Alvarez; Maneesh Paul-Satyaseela; Chidozie Declan Iwu; Clara Balleste-Delpierre; Ed Septimus; Lawrence Mugisha; Joseph Fadare; Susmita Chaudhuri; Vindana Chibabhai; J M Rohini W W Wadanamby; Ziad Daoud; Yonghong Xiao; Thulasiraman Parkunan; Yara Khalaf; Nkuchia M M'Ikanatha; Maarten B M van Dongen

doi:10.1093/jacamr/dlab038

The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective

Shamshul Ansari^*
, John P Hays
, Global AMR Insights Ambassador Network
, Andrew Kemp
, Raymond Okechukwu
, Jayaseelan Murugaiyan
, Mutshiene Deogratias Ekwanzala
, Maria Josefina Ruiz Alvarez
, Maneesh Paul-Satyaseela
, Chidozie Declan Iwu
, Clara Balleste-Delpierre
, Ed Septimus
, Lawrence Mugisha
, Joseph Fadare
, Susmita Chaudhuri
, Vindana Chibabhai
, J M Rohini W W Wadanamby
, Ziad Daoud
, Yonghong Xiao
, Thulasiraman Parkunan

Yara Khalaf, Nkuchia M M'Ikanatha, Maarten B M van Dongen

^*Corresponding author for this work

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

82 Citations (Scopus)

81 Downloads (Pure)

Abstract

The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.

Original language	English
Article number	dlab038
Journal	JAC-Antimicrobial Resistance
Volume	3
Issue number	2
DOIs	https://doi.org/10.1093/jacamr/dlab038 https://doi.org/10.1093/jacamr/dlab038
Publication status	Published - Jun 2021

Bibliographical note

Funding: This study was supported by internal funding.

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/jacamr/dlab038Licence: CC BY-NC
10.1093/jacamr/dlab038Licence: CC BY-NC

dlab038Final published version, 755 KBLicence: CC BY-NC

Cite this

Ansari, S., Hays, J. P., Global AMR Insights Ambassador Network , Kemp, A., Okechukwu, R., Murugaiyan, J., Ekwanzala, M. D., Ruiz Alvarez, M. J., Paul-Satyaseela, M., Iwu, C. D., Balleste-Delpierre, C., Septimus, E., Mugisha, L., Fadare, J., Chaudhuri, S., Chibabhai, V., Wadanamby, J. M. R. W. W., Daoud, Z., Xiao, Y., ... van Dongen, M. B. M. (2021). The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective. JAC-Antimicrobial Resistance, 3(2), Article dlab038. https://doi.org/10.1093/jacamr/dlab038, https://doi.org/10.1093/jacamr/dlab038

@article{49c46264a0674010ad7a81b14204bfb2,

title = "The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective",

abstract = "The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.",

author = "Shamshul Ansari and Hays, \{John P\} and \{Global AMR Insights Ambassador Network\} and Andrew Kemp and Raymond Okechukwu and Jayaseelan Murugaiyan and Ekwanzala, \{Mutshiene Deogratias\} and \{Ruiz Alvarez\}, \{Maria Josefina\} and Maneesh Paul-Satyaseela and Iwu, \{Chidozie Declan\} and Clara Balleste-Delpierre and Ed Septimus and Lawrence Mugisha and Joseph Fadare and Susmita Chaudhuri and Vindana Chibabhai and Wadanamby, \{J M Rohini W W\} and Ziad Daoud and Yonghong Xiao and Thulasiraman Parkunan and Yara Khalaf and M'Ikanatha, \{Nkuchia M\} and \{van Dongen\}, \{Maarten B M\}",

note = "Funding: This study was supported by internal funding. {\textcopyright} The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.",

year = "2021",

month = jun,

doi = "10.1093/jacamr/dlab038",

language = "English",

volume = "3",

journal = "JAC-Antimicrobial Resistance",

issn = "2632-1823",

publisher = "Oxford University Press",

number = "2",

}

Ansari, S, Hays, JP, Global AMR Insights Ambassador Network , Kemp, A, Okechukwu, R, Murugaiyan, J, Ekwanzala, MD, Ruiz Alvarez, MJ, Paul-Satyaseela, M, Iwu, CD, Balleste-Delpierre, C, Septimus, E, Mugisha, L, Fadare, J, Chaudhuri, S, Chibabhai, V, Wadanamby, JMRWW, Daoud, Z, Xiao, Y, Parkunan, T, Khalaf, Y, M'Ikanatha, NM & van Dongen, MBM 2021, 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective', JAC-Antimicrobial Resistance, vol. 3, no. 2, dlab038. https://doi.org/10.1093/jacamr/dlab038, https://doi.org/10.1093/jacamr/dlab038

TY - JOUR

T1 - The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance

T2 - An AMR Insights global perspective

AU - Ansari, Shamshul

AU - Hays, John P

AU - Global AMR Insights Ambassador Network

AU - Kemp, Andrew

AU - Okechukwu, Raymond

AU - Murugaiyan, Jayaseelan

AU - Ekwanzala, Mutshiene Deogratias

AU - Ruiz Alvarez, Maria Josefina

AU - Paul-Satyaseela, Maneesh

AU - Iwu, Chidozie Declan

AU - Balleste-Delpierre, Clara

AU - Septimus, Ed

AU - Mugisha, Lawrence

AU - Fadare, Joseph

AU - Chaudhuri, Susmita

AU - Chibabhai, Vindana

AU - Wadanamby, J M Rohini W W

AU - Daoud, Ziad

AU - Xiao, Yonghong

AU - Parkunan, Thulasiraman

AU - Khalaf, Yara

AU - M'Ikanatha, Nkuchia M

AU - van Dongen, Maarten B M

N1 - Funding: This study was supported by internal funding. © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

PY - 2021/6

Y1 - 2021/6

N2 - The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.

AB - The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.

UR - https://www.scopus.com/pages/publications/85114822348

U2 - 10.1093/jacamr/dlab038

DO - 10.1093/jacamr/dlab038

M3 - Article

C2 - 34192258

SN - 2632-1823

VL - 3

JO - JAC-Antimicrobial Resistance

JF - JAC-Antimicrobial Resistance

IS - 2

M1 - dlab038

ER -

The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this